GoodRx Holdings, Inc.

NASDAQ:GDRX

Medical - Healthcare Information Services

Healthcare
$3.36 +1.72%

+$0.05 today

Market cap
$1.15B
Beta
1.61
P/E (TTM)
44.0
EPS (TTM)
$0.06
52W Low $1.77High $5.81

Volume 0.66M

Average 1.61M

GDRX Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

GoodRx Holdings, Inc.NASDAQ: GDRX

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 21.7% from a year ago

Cash & equivalents stood at $235.71M at the end of Q1 FY2026, down 21.7% from a year earlier and down 10.0% from the prior quarter. Over 3 fiscal years it compounded at -29.8% a year.

Context

  • Cash & equivalents amounted to 11.7% of total assets at the end of Q1 FY2026, down 11.6 pp from a year earlier.
  • Cash & equivalents increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -21.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$235.71M-10.0% QoQ
Last fiscal yearDec 2025
$261.82M-41.6% YoY
Year agoMar 2025
$300.98M-21.7% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-21.7%——
1 year-41.6%——
3-year CAGR-29.8%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
261.82M USD
Year-over-year change
-41.6%
4-year CAGR
-27.4%

Cash & Equivalents vs competitors

How GDRX compares with its peers on the latest reported figures

  • GDRX's Mar 2026 cash & equivalents of $235.71M is the 2nd highest of the 4 companies compared; the peer median is $179.21M.
  • Its year-over-year change of -21.7% is the 3rd highest of 4, against a peer median of -19.4%.
  • Cash & equivalents amounts to 11.7% of total assets for GDRX, versus a peer median of 49.2%.
GDRX Competitors Peer median
Cash & Equivalents for GDRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TDOCTeladoc Health, Inc.Mar 2026$750.74M -37.1%-5.2%26.7%
GDRXGoodRx Holdings, Inc.Mar 2026$235.71M -21.7%-29.8%11.7%
AMWLAmerican Well CorporationMar 2026$179.21M -19.4%-30.3%55.0%
LFMDLifeMD, Inc.Mar 2026$34.48M +0.2%+110.2%49.2%
Peer median (excluding GDRX) $179.21M-19.4%-5.2%49.2%

Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents941.11M757.17M672.3M448.35M261.82M
Short-term Investments00000
Net Receivables126.41M121.67M160.05M160.83M254.87M
Inventory00000
Other Current Assets21.31M35.11M40.45M50.08M126.41M
Total Current Assets1.09B919.69M872.79M659.26M643.1M
Property, Plant & Equipment (Net)49.32M55.73M45.86M40.46M41.08M
Goodwill329.7M412.12M410.77M410.77M430.33M
Intangible Assets133.78M189.94M156.34M176.88M203.34M
Long-term Investments4M19M000
Tax Assets0065.27M77.18M57.11M
Other Non-current Assets2.01M8.17M37.78M23.52M29.1M
Total Non-current Assets518.8M684.95M716.01M728.81M760.96M
Total Assets1.61B1.6B1.59B1.39B1.4B
Account Payables17.5M17.7M36.27M14.14M19.41M
Short-term Debt7.03M7.03M8.79M5M5M
Tax Payables0001.46M0
Deferred Revenue6.87M7.88M7.11M6.04M6.71M
Other Current Liabilities00015.8M130.14M
Total Current Liabilities81.11M76.32M122.56M123.9M246M
Long-term Debt655.86M651.8M647.7M486.71M483.26M
Deferred Tax Liabilities244K0000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.14M7.56M8.18M6.76M8.74M
Total Non-current Liabilities694.83M713.48M704.28M539.51M541.79M
Total Liabilities775.95M789.8M826.84M663.41M787.8M
Common Stock40K40K40K38K34K
Retained Earnings(1.42B)(1.45B)(1.46B)(1.44B)(1.41B)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity831.68M814.83M761.96M724.66M616.26M
Total Debt702.33M717.02M711.07M543.39M542.81M
Net Debt(238.78M)(40.14M)38.77M95.04M280.99M

GoodRx Holdings, Inc.

NASDAQ:GDRX

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.